Biogen (BIIB) Tops Q1 EPS by 12c, Offers Guidance
Tweet
Share
E-mail
Get Alerts BIIB Hot Sheet
Price: $212.50 -3.77%
EPS Growth %: -57.8%
Financial Fact:
Product: 2.54B
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -57.8%
Financial Fact:
Product: 2.54B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Biogen (NASDAQ: BIIB) reported Q1 EPS of $3.40, $0.12 better than the analyst estimate of $3.28. Revenue for the quarter came in at $2.46 billion versus the consensus estimate of $2.34 billion.
GUIDANCE:
Biogen sees FY2023 EPS of $15.00-$16.00, versus the consensus of $15.48.
- Total revenue Mid-single digit percentage decline versus reported full year 2022
For earnings history and earnings-related data on Biogen (BIIB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- Barnes & Noble Education (BNED) Tops Q1 EPS by 12c
- UBS upgrades Lockheed Martin to Buy, sees 26% upside on missile growth
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
